Efficacy and safety of capecitabine and temozolomide (CAPTEM) in advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) - A systematic review and metanalysis

M. Tacelli,S. Massironi,C. Gallo,N. Bina,C. Stornello,P. G. Arcidiacono,G. Capurso

Pancreatology（2023）

引用 0|浏览4

暂无评分

摘要

Aims The combination of capecitabine and temozolomide (CAPTEM) is increasingly used for advanced gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN), but evidence on results is sparse.We conducted a systematic review and meta-analysis to assess efficacy and safety of CAPTEM in advanced GEP-NEN

查看译文

关键词

neuroendocrine,capecitabine,gastro-entero-pancreatic,gep-nen

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要